References
1. Vissing-Uhre R, Hansen A, Frevert S, Hansen D. Rituximab Treatment in
a Patient with Kimura Disease and Membranous Nephropathy: Case Report.
Case Rep Nephrol Dial. 2021;11(2):116-23.
2. Zhang X, Jiao Y. The clinicopathological characteristics of Kimura
disease in Chinese patients. Clin Rheumatol. 2019;38(12):3661-7.
3. Sousa CP, Fonseca E, Viamonte B, Lobo JC, Madureira A. Kimura’s
disease: a rare cause of facial mass in a caucasian male patient. BJR
Case Rep. 2020;6(4):20200099.
4. Wang D, Mao J, Zhang Y, Gu W, Zhao S, Chen Y, et al. Kimura disease:
a case report and review of the Chinese literature. Nephron Clinical
Practice. 2009;111(1):c55-c61.
5. Ren S, Li XY, Wang F, Zhang P, Zhang Y, Li GS, et al. Nephrotic
syndrome associated with Kimura’s disease: a case report and literature
review. BMC Nephrol. 2018;19(1):316.
6. Glibbery N, Muscat K, Cascarini L. Kimura’s disease of the parotid
gland with cutaneous features in a Caucasian female patient. Journal of
surgical case reports. 2018;2018(4):rjy067.
7. Kottler D, Barète S, Quéreux G, Ingen-Housz-Oro S, Fraitag S, Ortonne
N, et al. Retrospective multicentric study of 25 Kimura disease
patients: emphasis on therapeutics and shared features with cutaneous
IgG4-related disease. Dermatology. 2015;231(4):367-77.
8. Nonaka M, Sakitani E, Yoshihara T. Anti-IgE therapy to Kimura’s
disease: a pilot study. Auris Nasus Larynx. 2014;41(4):384-8.
9. Hosaka N, Minato T, Yoshida S, Toki J, Yang G, Hisha H, et al.
Kimura’s disease with unusual eosinophilic epithelioid granulomatous
reaction: a finding possibly related to eosinophil apoptosis. Human
pathology. 2002;33(5):561-4.
10. Deng W-Y, Ye S-B, Luo R-Z, Yan S-M, Gao Y-F, Yang Y-Z, et al.
Notch-1 and Ki-67 receptor as predictors for the recurrence and
prognosis of Kimura’s disease. International journal of clinical and
experimental pathology. 2014;7(5):2402.
11. Zhang G, Li X, Sun G, Cao Y, Gao N, Qi W. Clinical analysis of
Kimura’s disease in 24 cases from China. BMC Surg. 2020;20(1):1.
12. Glibbery N, Muscat K, Cascarini L. Kimura’s disease of the parotid
gland with cutaneous features in a Caucasian female patient. J Surg Case
Rep. 2018;2018(4):rjy067.
13. Zhang G, Li X, Sun G, Cao Y, Gao N, Qi W. Clinical analysis of
Kimura’s disease in 24 cases from China. BMC surgery. 2020;20(1):1-6.
14. Rajpoot DK, Pahl M, Clark J. Nephrotic syndrome associated with
Kimura disease. Pediatr Nephrol. 2000;14(6):486-8.
15. Okura T, Miyoshi K-i, Irita J, Enomoto D, Nagao T, Kukida M, et al.
Kimura’s disease associated with membranous nephropathy with IgG4 and
phospholipase A2 receptor-positive staining of the glomerular basement
membrane. Internal Medicine. 2014;53(13):1435-40.
16. Ye P, Ma DQ, Yu GY, Gao Y, Peng X. Comparison of the efficacy of
different treatment modalities for Kimura’s disease. Int J Oral
Maxillofac Surg. 2017;46(3):350-4.
17. Fan L, Mo S, Wang Y, Zhu J. Clinical, pathological, laboratory
characteristics, and treatment regimens of Kimura disease and their
relationships with tumor size and recurrence. Frontiers in Medicine.
2021:1737.
18. Iwai H, Nakae K, Ikeda K, Ogura M, Miyamoto M, Omae M, et al. Kimura
disease: diagnosis and prognostic factors. Otolaryngology–Head and
Neck Surgery. 2007;137(2):306-11.
19. Fouda MA, Gheith O, Refaie A, El-Saeed M, Bakr A, Wafa E, et al.
Kimura disease: a case report and review of the literature with a new
management protocol. Int J Nephrol. 2011;2010:673908.
20. Chen Y, Wang J, Xu F, Zeng C, Liu Z. Clinicopathological features
and prognosis of Kimura’s disease with renal involvement in Chinese
patients. Clin Nephrol. 2016;85(6):332-9.
21. Sato S, Kawashima H, Kuboshima S, Watanabe K, Kashiwagi Y, Takekuma
K, et al. Combined treatment of steroids and cyclosporine in Kimura
disease. Pediatrics. 2006;118(3):e921-e3.
22. Wang YS, Tay YK, Tan E, Poh WT. Treatment of Kimura’s disease with
cyclosporine. Journal of dermatological treatment. 2005;16(4):242-4.
23. Soeria‐Atmadja S, Oskarsson T, Celci G, Sander B, Berg U, Gustafsson
B. Maintenance of remission with cyclosporine in paediatric patients
with Kimura′ s disease–two case reports. Acta Paediatrica.
2011;100(10):e186-e9.
24. Katagiri K, Itami S, Hatano Y, Yamaguchi T, Takayasu S. In vivo
expression of IL‐4, IL‐5, IL‐13 and IFN‐γ mRNAs in peripheral blood
mononuclear cells and effect of cyclosporin A in a patient with Kimura’s
disease. British Journal of Dermatology. 1997;137(6):972-7.
25. Zhang X, Jiao Y. The clinicopathological characteristics of Kimura
disease in Chinese patients. Clinical Rheumatology. 2019;38(12):3661-7.
26. Yang S, Wang J, Chen Y, Jiang Z, Zhong T, Dong Y, et al. Concurrent
kidney glomerular and interstitial lesions associated with Kimura’s
disease. Nephron. 2019;143(2):92-9.
27. Itami J, Arimizu N, Miyoshi T, Ogata H, Miura K. Radiation therapy
in Kimura’s disease. Acta Oncologica. 1989;28(4):511-4.
Table 1 Clinical laboratory findings